Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...

After Trump signed an executive order cutting NIH funds to universities, this Rushville-born professor is seeing the negative effects ...

A recent study on cell-cultivated fish has produced promising results that could put seafood back on the menu for the three ...

On January 28, 2025, the Company received clearance of its IND from the FDA to initiate a first-in-human Phase 1 dose ...

A leaked memo for grant management staff of the US government's National Institutes of Health, dated 25 March, instructs ...

A Dundee academic has been awarded a prestigious national prize for his work on neurodegenerative diseases, including ...

Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

To promote research in Unani system of medicine, Ministry of Ayush, the Government of India has set up the Central Council of Research in Unani Medicine (CCRUM), New Delhi and National Institute of ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the fourth ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results ...